Synthesis and in vitro antiviral activities of 3'-fluoro (or chloro) and 2',3'-difluoro 2',3'-dideoxynucleoside analogs against hepatitis B and C viruses. 2010

Naveen C Srivastav, and Neeraj Shakya, and Michelle Mak, and Chao Liang, and D Lorne J Tyrrell, and Babita Agrawal, and Rakesh Kumar
Department of Laboratory Medicine and Pathology, 1-71 Medical Sciences Building, University of Alberta, Edmonton, AB, Canada T6G 2H7.

Chronic infections with hepatitis B virus (HBV) and hepatitis C virus (HCV) lead to serious liver diseases worldwide. Co-infection with HBV and HCV is very common and is associated with increased risk of liver pathogenesis, liver cancer, and liver failure. Several 5-substituted 3'-fluoro (or chloro) (1-4, 6, 7, 17-19) and 2',3'-difluoro 2',3'-dideoxynucleosides (15 and 16) were synthesized and evaluated for in vitro antiviral activities against duck hepatitis B virus (DHBV), human hepatitis B virus, and hepatitis C virus. Of these compounds 4, 7, 17, and 19 demonstrated moderate anti-HBV activity, and 2, 4, 7, 8, and 19 were weak inhibitors of HCV. Although 5-iodo derivative (7) was most inhibitory against HCV, it exhibited a reduction in cellular RNA levels in Huh-7 cells. The 5-hydroxymethyl-3'-fluoro-2',3'-dideoxyuridine (4) and 1-(3-chloro-2,3-dideoxy-β-d-erythro-pentofuranosyl)-5-fluorouracil (19) provided the most inhibition of both viruses without cytotoxicity.

UI MeSH Term Description Entries
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D015224 Dideoxynucleosides Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription. 2',3'-Dideoxynucleosides,Dideoxyribonucleosides,ddNus,2',3' Dideoxynucleosides
D015611 Hepatitis B Virus, Duck A DNA virus that closely resembles human hepatitis B virus. It has been recovered from naturally infected ducks. DHBV,Duck hepatitis B virus,Duck Hepatitis B Viruses,Hepatitis B Viruses, Duck
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Naveen C Srivastav, and Neeraj Shakya, and Michelle Mak, and Chao Liang, and D Lorne J Tyrrell, and Babita Agrawal, and Rakesh Kumar
May 1997, Antiviral research,
Naveen C Srivastav, and Neeraj Shakya, and Michelle Mak, and Chao Liang, and D Lorne J Tyrrell, and Babita Agrawal, and Rakesh Kumar
April 2022, Molecules (Basel, Switzerland),
Naveen C Srivastav, and Neeraj Shakya, and Michelle Mak, and Chao Liang, and D Lorne J Tyrrell, and Babita Agrawal, and Rakesh Kumar
June 1988, Antimicrobial agents and chemotherapy,
Naveen C Srivastav, and Neeraj Shakya, and Michelle Mak, and Chao Liang, and D Lorne J Tyrrell, and Babita Agrawal, and Rakesh Kumar
January 2016, Beilstein journal of organic chemistry,
Naveen C Srivastav, and Neeraj Shakya, and Michelle Mak, and Chao Liang, and D Lorne J Tyrrell, and Babita Agrawal, and Rakesh Kumar
January 1992, Biochemical pharmacology,
Naveen C Srivastav, and Neeraj Shakya, and Michelle Mak, and Chao Liang, and D Lorne J Tyrrell, and Babita Agrawal, and Rakesh Kumar
October 1993, Acta virologica,
Naveen C Srivastav, and Neeraj Shakya, and Michelle Mak, and Chao Liang, and D Lorne J Tyrrell, and Babita Agrawal, and Rakesh Kumar
January 1991, Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie,
Naveen C Srivastav, and Neeraj Shakya, and Michelle Mak, and Chao Liang, and D Lorne J Tyrrell, and Babita Agrawal, and Rakesh Kumar
December 1988, Antiviral research,
Naveen C Srivastav, and Neeraj Shakya, and Michelle Mak, and Chao Liang, and D Lorne J Tyrrell, and Babita Agrawal, and Rakesh Kumar
March 2022, European journal of medicinal chemistry,
Naveen C Srivastav, and Neeraj Shakya, and Michelle Mak, and Chao Liang, and D Lorne J Tyrrell, and Babita Agrawal, and Rakesh Kumar
December 2003, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!